KYVERNA THERAPEUTICS INC (KYTX) Stock Balance Sheet
NASDAQ:KYTX - Nasdaq - US5019761049 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 56.87M | 96.62M | 34.65M | 37.73M | 76.07M | |||
| Marketable Securities | 185.78M | 189.36M | 22.90M | 13.59M | 0.00 | |||
| Other Current Assets | 5.00M | 4.62M | 3.12M | 1.93M | 1.02M | |||
| Total Current Assets | 247.65M | 290.60M | 60.66M | 53.25M | 77.09M | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.80M | 10.66M | 10.61M | 12.44M | 7.81M | |||
| Other Non-Current Assets | 4.20M | 3.39M | 3.92M | 1.23M | 593.00K | |||
| Total Non-Current Assets | 13.00M | 14.04M | 14.53M | 13.67M | 8.40M | |||
| TOTAL ASSETS | 260.65M | 304.64M | 75.19M | 66.92M | 85.49M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 507.00K | 779.00K | 956.00K | 605.00K | 42.00K | |||
| Accrued Expenses | 12.41M | 14.29M | 11.03M | 9.33M | 8.54M | |||
| Accounts Payable | 8.47M | 4.62M | 4.36M | 1.45M | 773.00K | |||
| Other Current Liabilities | 11.91M | 14.06M | 3.52M | 565.00K | 6.58M | |||
| Total Current Liabilities | 33.29M | 33.76M | 19.86M | 11.95M | 15.93M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 73.00K | 142.00K | 921.00K | 1.08M | 18.00K | |||
| Other Non-Current Liabilities | 3.28M | 4.16M | 5.24M | 7.21M | 7.08M | |||
| Total Non-Current Liabilities | 3.35M | 4.30M | 6.16M | 8.29M | 7.09M | |||
| TOTAL LIABILITIES | 36.65M | 38.06M | 26.02M | 20.25M | 23.02M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -308.15M | -263.52M | -136.04M | -75.68M | -46.78M | |||
| Additional Paid In Capital | 532.17M | 530.00M | 4.64M | 1.71M | 530.00K | |||
| Common Shares | N/A | 400.00 | 180.57M | 120.67M | 108.72M | |||
| Other Shareholders' Equity | N/A | -400.00 | -400.00 | -26.00K | 0.00 | |||
| Shares Outstanding | 43.22M | 43.21M | 43.12M | 40.82M | 40.82M | |||
| Tangible Book Value per Share | 5.18 | 6.17 | -3.05 | -1.81 | -1.13 | |||
| Total Shareholders' Equity | 224.01M | 266.59M | 49.18M | 46.68M | 62.47M | |||
| TOTAL LIABILITIES AND EQUITY | 260.65M | 304.64M | 75.19M | 66.92M | 85.49M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.02 | 0.02 | 0.00 | |||
| Current Ratio | 7.44 | 8.61 | 3.05 | 4.45 | 4.84 | |||
| Return On Assets (ROA) | -55.87% | -41.69% | -80.28% | -43.17% | -30.82% | |||
| Return On Equity (ROE) | -65.00% | -47.64% | -122.75% | -61.90% | -42.18% | |||
All data in USD , ROIC based on taxRate of 0.21